ARGANOVA 100 mg/ml, concentrate for solution for infusion in multi-dose bottle, 5 ml
Active ingredients: (21r)-argatroban monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARGANOVA 100 mg/mL, solution à diluer pour perfusion en multidose
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre multidose de 5 ml contenant 2,5 ml de solution à diluer
- Marketing authorisation holder
- ETHYPHARM
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jan 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65905051CIP72774800CIP133400927748004Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARGATROBAN MONOHYDRATÉsolution | 100 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.